hit tracker
Sunday, July 14, 2024
HomeLatest NewsThe Russian labeling system can become a model for the whole world

The Russian labeling system can become a model for the whole world

Date: July 14, 2024 Time: 12:56:33

Deputy Minister of Industry and Trade Ekaterina Priezzheva

Photo: Konstantin OLKHIN.

“MANY TASKS, NO TIME TO BALANCE”

– Ekaterina Gennadievna, the Farma-2030 strategy is one year old. What are the results of the first year of this strategy?

– In fact, exactly a year ago our new strategy for the development of the pharmaceutical industry until 2030 was adopted.

We have a plan to implement this strategy, which consists of 40 large blocks. These are the tasks we have to solve in the next six years. And 14 points of this plan must be completed within one year. It involves, for example, clarification and “clarification” of issues related to patent law; issues of organization and traceability of raw materials and pharmaceutical substances for the production of medicines and in 2025, for example, the list of medicines of strategic importance should be reviewed and updated. Separately, I would like to note that an assessment of the current need for medicines is currently being carried out, which will make it possible to plan the processes of development and (or) organization of their production, and a mechanism for determining competencies is also being formed. key, therapeutic areas and technologies necessary for the health system, which will serve as a guide for our manufacturers.

A large block of issues is related to personnel. This is not just an industry problem: all industries need high-level, well-trained specialists.

There are many other questions. Therefore, we do not have time to balance, there are many tasks. Little by little we are moving forward in its solution.

The main block of these tasks should be implemented by the end of 2026, although the Strategy itself is designed until 2030. Next, we will look at what we have achieved, where correction is needed and formulate an edition of the plan for 2027-2030.

GOVERNMENT SUPPORT MEASURES FOR THE ELECTION

– What measures is the government taking to support the pharmaceutical industry?

– The set of support measures is very broad.

Within the framework of the Industrial Development Fund, we have a number of instruments (preferential loans), including for equipment and for the purchase of equipment. In total there are around 8 options for state support programs.

There is such a new tool as the cluster investment platform – it is also long-term preferential loans. In addition, we plan to provide this measure of state support to companies that produce innovative and currently priority medicines. Pharmaceutical companies can use preferential loans for both drug development and capital investments.

There is a supporting measure called “products on the shelf.” We give subsidies to manufacturers for the development of medicines, for which we must eliminate the risk of defects (lack of necessary medicines in the pharmacy – Ed.). But our manufacturers respect patent laws and other people’s intellectual property. Therefore, they develop this medicine, register it and put it into circulation only if the patent for this medicine expires or if force majeure occurs and manufacturers from hostile countries leave the market and take away the products in demand. Then we have the opportunity to quickly provide the patient with access to the necessary medications.

We also have our PharmMed Innovations fund. Its financial instruments are intended for the development and cultivation of young projects, including the creation of innovative medicines. Here we recall again a special investment contract, which provides for the granting of tax benefits to its holders.

In general, there are many measures and representatives of the pharmaceutical industry can choose one of them or a combined option.

– Mentioned innovative developments. Is there any success in this area and what are the forecasts?

– The development of innovative drugs is one of our priorities in the medium and long term. By the way, in the SPIEF sessions special importance is given to this area: we just had a session in which innovation was discussed. I would like to note that over the past 10 years our manufacturers have acquired very serious competencies. They can manufacture not only generic medicines, but also innovative ones.

And success in this area is already evident. I can name Biocad, Generium, Geropharm, Promomed, R-Pharm and other companies that are currently bringing such drugs to the market. It is clear that this work carries risks; after all, it is never clear how preclinical and clinical studies will end up, and all this requires large investments…

But everyone knows that the task of developing innovative drugs is of particular importance. After all, it is as much about our sovereignty as it is about ensuring the safety of medicines. And today, in my opinion, a real help for the development of this innovative activity will be the development of a fast track that will allow these developed medicines to reach the market very quickly.

In recent years, the Russian pharmaceutical industry has learned to respond to all existing challenges and threats. The course of import substitution that our country has taken has already allowed us to form our own base in the pharmaceutical industry, and thanks to this base, today both generics and our own medicines are produced in our country. Russian pharmaceutical companies have significantly expanded and increased production volumes, as well as the necessary competencies.

Our products are currently supplied to more than 150 countries around the world and the geography continues to expand steadily. We are ready to develop cooperation and consider that the localization of development and production on the territory of the BRICS member countries is another direction. In addition to mutual trade, it is necessary to develop cooperation in the development and production of medicines and medical products in the BRICS countries.”

FIGHT AGAINST COUNTERFEITS

– Today, online trade is actively developing and more and more suppliers from new countries appear. And in this sense, the fight against illegal products and counterfeits becomes especially intense. Are there mechanisms that allow you to control and monitor all this?

– Certainly. In Russia there is a well-known mechanism that has been used for five years: the digital product labeling system. June 7 marks exactly five years since we signed a public-private partnership agreement here at the St. Petersburg International Economic Forum. And today this system is already widespread.

The mandatory labeling system already includes 17 product groups. And if we talk about such a rapidly growing commercial sector as markets, from September 1 they will also become mandatory participants in this system. This will allow consumers who use these services and order products online to have confidence that they are receiving truly safe and legally produced products (if subject to mandatory labeling).

By the way, almost all the largest markets (Ozon, Wildberries, Yandex Market and others) are already working on this system today. And from September 1, this will be mandatory for everyone and our markets will not have the right to offer consumers products produced in violation of labeling requirements.

– Does this apply to any products?

– Those same 17 groups of products that are subject to labeling (milk, fur coats, tires, shoes, perfumes, etc. – Ed.). And medicines are one of the first groups of products that began to be labeled. This has been happening since 2019.

MARKING GOES AROUND THE PLANET

– What role does labeling play in international cooperation? Is this a barrier to import?

– Vice versa. It is labeling that eliminates trade barriers and creates a barrier-free space on the territory of our partner countries in the Eurasian Economic Union (which includes Russia, Belarus, Armenia, Kazakhstan and Kyrgyzstan – Ed.). To date, this system has been implemented in all EAEU states. It is true that in different countries it works for different products, but my EAEU colleagues and I agree on common approaches to labeling. And we label products according to a single model, in the same way.

We guarantee mutual recognition of codes so that there is no double marking with codes from other countries. That is, mutual recognition of codes is guaranteed.

And this practice is used even more widely than in the EAEU. Because, for example, Uzbekistan is now also very actively participating in this system. They are introducing a labeling system and the same basic approaches and principles that apply in the Russian Federation.

– But we import products, including medicines, not only from the EAEU, but also from several countries: France, Germany, India, USA… And imported products must also be labeled. Is there any problem in this regard?

– For imported medicines and other goods subject to labeling, we have several options.

The first option is that the manufacturer can supply the equipment and label its products, which are produced for the Russian market. And many representatives of Big Pharma, that is, large pharmaceutical companies, did just that. Because it is cheaper, easier and you control the marking process yourself.

The second way is that they can label products at special border centers (large transport hubs – Ed.). It looks like this: unlabeled products, which are intended specifically for our country, are brought to specially created border structures, where they are labeled by contract and then brought to the Russian Federation.

And the third option, by the way, the most popular, is to label in a customs warehouse that is already located on the territory of Russia before its release into circulation by the federal customs service.

– In summary: what role does labeling play in international cooperation?

– As already said, this system already exists in the EAEU, it is scalable and sometimes even our partners label products that we do not label yet. They may be those goods that they consider most vulnerable from the point of view of their economy, or there is illegal trade in said goods and they consider it necessary to label them.

If we talk about third countries, there is also interest in the labeling system. This year we participated in a meeting of the World Health Organization and presented our labeling system as a traceability system for tobacco products. And I can proudly say that our traceability system seemed very decent. It is truly unique; There are no analogues of this type of systems in the world. And at this WHO meeting, the Russian digital labeling system was proposed as an ideal system that could become the basis for its implementation around the world.

MANUFACTURED AND SUPPORTED IN RUSSIA

– Ekaterina Gennadievna, how can a labeling system help business development?

– Today they talked a lot about this on the forum. And the business itself spoke.

What are the main advantages that entrepreneurs cite for themselves in the labeling system? First of all, it is to have reliable online information about your products. This helps them solve packaging problems, price control, timely production and avoid shortages of their products, carry out promotions and reduce sales on networks, for example, of expired products. The information we provide to manufacturers and importers from the labeling database is, in my opinion, the most popular option.

Second, manufacturers said they could trace the origin of the raw materials from which their products were made. Now the labeling system is used as confirmation of “Russianness” – production in the Russian Federation.

Now the State grants preferences and various benefits to national products; At least that trend exists in public procurement. And the higher the level of localization of the product, the more preferences it has. Naturally, the labeling system helps us with this; confirms the Russian origin not only of the finished product, but also of the components and assemblies found inside.

* This website provides news content gathered from various internet sources. It is crucial to understand that we are not responsible for the accuracy, completeness, or reliability of the information presented Read More

Puck Henry
Puck Henry
Puck Henry is an editor for ePrimefeed covering all types of news.
RELATED ARTICLES

Most Popular

Recent Comments